| 國立成功大學 |
2021 |
Epigenome-wide association study on asthma and chronic obstructive pulmonary disease overlap reveals aberrant DNA methylations related to clinical phenotypes
|
Chen, Y.-C.;Tsai, Y.-H.;Wang, C.-C.;Liu, S.-F.;Chen, T.-W.;Fang, W.-F.;Lee, C.-P.;Hsu, P.-Y.;Chao, T.-Y.;Wu, C.-C.;Wei, Y.-F.;Chang, H.-C.;Tsen, C.-C.;Chang, Y.-P.;Lin, M.-C.;Yu, C.-J.;Wang, H.-C.;Chiang, Chiang C.-H.;Perng, D.-W.;Cheng, S.-L.;Hsu, J.-Y.;Hsu, W.-H.;Hsiue, T.-R.;Lin, H.-I.;Wang, C.-Y.;Chang, Y.-C.;Chen, Chen C.-M.;Lin, C.-S.;Chen, L.;Chong, I.-W.;group, Taiwan Clinical Trial Consortium of Respiratory Disease (TCORE) |
| 臺大學術典藏 |
2020-08-13T05:24:05Z |
Epidemiology and Predictors of NTM Pulmonary Infection in Taiwan - A Retrospective, Five-Year Multicenter Study
|
Huang H.-L.; Cheng M.-H.; Lu P.-L.; Lee L.-N.; Shu C.-C.; JANN-YUAN WANG; Wang J.-T.; Chong I.-W. |
| 臺大學術典藏 |
2020-08-13T05:24:01Z |
Surgical resection is sufficient for incidentally discovered solitary pulmonary nodule caused by nontuberculous mycobacteria in asymptomatic patients
|
Lu P.-L.; JANN-YUAN WANG; Chong I.-W.; Cheng M.-H.; Lee M.-R.; Liu C.-J.; Huang H.-L.; Huang H.-L.;Liu C.-J.;Lee M.-R.;Cheng M.-H.;Lu P.-L.;Jann-Yuan Wang;Chong I.-W. |
| 臺大學術典藏 |
2020-08-13T05:23:58Z |
Predictors of radiographic progression for NTM–pulmonary disease diagnosed by bronchoscopy
|
Huang H.-L.;Lee M.-R.;Liu C.-J.;Cheng M.-H.;Lu P.-L.;Jann-Yuan Wang;Chong I.-W.; Huang H.-L.; Lee M.-R.; Liu C.-J.; Cheng M.-H.; Lu P.-L.; JANN-YUAN WANG; Chong I.-W. |
| 臺大學術典藏 |
2020-08-13T05:23:56Z |
Seroprevalence of Aspergillus IgG and disease prevalence of chronic pulmonary aspergillosis in a country with intermediate burden of tuberculosis: a prospective observational study
|
JANN-YUAN WANG; Dimopoulos G.; Lee L.-N.; Chong I.-W.; Cheng M.-H.; Ko J.-C.; Yang H.-C.; Chen L.-C.; Huang H.-L.; Lee M.-R.; Lee M.-R.;Huang H.-L.;Chen L.-C.;Yang H.-C.;Ko J.-C.;Cheng M.-H.;Chong I.-W.;Lee L.-N.;Jann-Yuan Wang;Dimopoulos G. |
| 臺大學術典藏 |
2020-08-12T07:46:56Z |
Risk of sepsis among patients with COPD treated with fixed combinations of inhaled corticosteroids and long-acting Beta2 agonists
|
Chen C.-Y.; On the behalf of Taiwan Clinical Trial Consortium for Respiratory Diseases (TCORE); Lai C.-C.; HAO-CHIEN WANG; Chen L.; Yu C.-J.; Yu C.-J.; HAO-CHIEN WANG; Perng D.-W.; Cheng S.-L.; Hsu J.-Y.; Hsu W.-H.; Tsai Y.-H.; Hsiue T.-R.; Lin M.-C.; Lin H.-I.; Wang C.-Y.; Chang Y.-C.; Yang U.-C.; Chen C.-M.; Lin C.-S.; Chen L.; Wei Y.-F.; Chong I.-W.; Wang Y.-H.; Lin Y.S.; Wang C.-Y.; Wang C.-Y.;Lin Y.S.;Wang Y.-H.;Lai C.-C.;Hao-Chien Wang;Chen L.;Yu C.-J.;Yu C.-J.;Hao-Chien Wang;Perng D.-W.;Cheng S.-L.;Hsu J.-Y.;Hsu W.-H.;Tsai Y.-H.;Hsiue T.-R.;Lin M.-C.;Lin H.-I.;Wang C.-Y.;Chang Y.-C.;Yang U.-C.;Chen C.-M.;Lin C.-S.;Chen L.;Wei Y.-F.;Chong I.-W.;Chen C.-Y.;On The Behalf Of Taiwan Clinical Trial Consortium For Respiratory Diseases (Tcore) |
| 臺大學術典藏 |
2020-08-12T06:34:18Z |
Risk of sepsis among patients with COPD treated with fixed combinations of inhaled corticosteroids and long-acting Beta2 agonists
|
Wang C.-Y.; Lin Y.S.; Wang Y.-H.; Lai C.-C.; Wang H.-C.; Chen L.; CHONG-JEN YU; CHONG-JEN YU; Wang H.-C.; Perng D.-W.; Cheng S.-L.; Hsu J.-Y.; Hsu W.-H.; Tsai Y.-H.; Hsiue T.-R.; Lin M.-C.; Lin H.-I.; Wang C.-Y.; Chang Y.-C.; Yang U.-C.; Chen C.-M.; Lin C.-S.; Chen L.; Wei Y.-F.; Chong I.-W.; Chen C.-Y.; On the behalf of Taiwan Clinical Trial Consortium for Respiratory Diseases (TCORE); Wang C.-Y.;Lin Y.S.;Wang Y.-H.;Lai C.-C.;Wang H.-C.;Chen L.;Chong-Jen Yu;Chong-Jen Yu;Wang H.-C.;Perng D.-W.;Cheng S.-L.;Hsu J.-Y.;Hsu W.-H.;Tsai Y.-H.;Hsiue T.-R.;Lin M.-C.;Lin H.-I.;Wang C.-Y.;Chang Y.-C.;Yang U.-C.;Chen C.-M.;Lin C.-S.;Chen L.;Wei Y.-F.;Chong I.-W.;Chen C.-Y.;On The Behalf Of Taiwan Clinical Trial Consortium For Respiratory Diseases (Tcore) |
| 臺大學術典藏 |
2020-08-12T06:34:14Z |
Nivolumab safety and efficacy in advanced, platinum-resistant, non-small cell lung cancer, radical radiotherapy-ineligible patients: A phase II study in Taiwan
|
Chen Y.-M.;Chih-Hsin Yang J.;Su W.-C.;Chong I.-W.;Hsia T.-C.;Lin M.-C.;Chang G.-C.;Chiu C.-H.;Ho C.-C.;Wu S.-Y.;Hung J.-Y.;Wang C.-C.;Yang T.-Y.;Chong-Jen Yu; Chen Y.-M.; Chih-Hsin Yang J.; Su W.-C.; Chong I.-W.; Hsia T.-C.; Lin M.-C.; Chang G.-C.; Chiu C.-H.; Ho C.-C.; Wu S.-Y.; Hung J.-Y.; Wang C.-C.; Yang T.-Y.; CHONG-JEN YU |
| 臺大學術典藏 |
2020-08-12T02:50:35Z |
Nivolumab safety and efficacy in advanced, platinum-resistant, non-small cell lung cancer, radical radiotherapy-ineligible patients: A phase II study in Taiwan
|
Chen Y.-M.;Chih-Hsin Yang J.;Su W.-C.;Chong I.-W.;Hsia T.-C.;Lin M.-C.;Chang G.-C.;Chiu C.-H.;Chao-Chi Ho;Wu S.-Y.;Hung J.-Y.;Wang C.-C.;Yang T.-Y.;Yu C.-J.; Chen Y.-M.; Chih-Hsin Yang J.; Su W.-C.; Chong I.-W.; Hsia T.-C.; Lin M.-C.; Chang G.-C.; Chiu C.-H.; CHAO-CHI HO; Wu S.-Y.; Hung J.-Y.; Wang C.-C.; Yang T.-Y.; Yu C.-J. |
| 臺大學術典藏 |
2020-07-21T06:46:14Z |
Nivolumab safety and efficacy in advanced, platinum-resistant, non-small cell lung cancer, radical radiotherapy-ineligible patients: A phase II study in Taiwan
|
Chen Y.-M.; Chih-Hsin Yang J.; Su W.-C.; Chong I.-W.; Hsia T.-C.; Lin M.-C.; Chang G.-C.; Chiu C.-H.; CHAO-CHI HO; Wu S.-Y.; Hung J.-Y.; Wang C.-C.; Yang T.-Y.; Yu C.-J. |
